Squawk on the Street
Moderna Cuts Vaccine Outlook, Qualcomm Shares Surge, Kyndryl Begins Trading
This episode isn’t summarized yet
Create a free account and summarize it. In a few minutes you’ll have the key takeaways and a section-by-section summary.
Show notes
Carl Quintanilla, Jim Cramer and David Faber began the show with a look at Moderna shares sliding, after cutting its Covid-19 vaccine sales forecast. The company is now expecting to deliver between 700-800 million does this year, down from previous expectations of between 800 million and 1 billion doses. The anchors also interviewed Qualcomm CEO, Cristiano Amon, a day after the company reported a strong earnings beat. Qualcomm’s chip sales for smartphones were up 56% year over year. Also in the mix: IBM spinoff Kyndryl began trading at the NYSE under ticker “KD.” CEO Martin Schroeter joined the crew ahead of the newly public company’s first trade. Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com
for information about our collection and use of personal data for
advertising.